Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chong Kun Dang Healthcare (CKDHC) is a leading South Korean consumer healthcare company and a subsidiary of the Chong Kun Dang Group. The company specializes in the development, manufacturing, and marketing of health functional foods, nutraceuticals, and over-the-counter (OTC) products. Its flagship brand, Lacto-Fit, is one of the most recognized probiotic brands in Korea, holding a significant market share in the gut health segment. CKDHC leverages the pharmaceutical expertise of its parent group to ensure high standards of quality and efficacy across its diverse product portfolio, which also includes vitamins, omega-3 supplements, and beauty-focused health products. The company is actively expanding its global footprint, targeting international markets with its science-backed wellness solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CKDHC.